Since late 2022, bad news in biotech has been nearly inescapable: flopped trials, slashed drug pipelines, bankruptcies and ...

Overall, biotech layoffs claimed at least 10,000 jobs within the sector last year, according to data compiled by BioPharma Dive. Many of those jobs were at smaller biotech companies more ...

Gina Calvanese got laid off from Jounce Therapeutics, a struggling Cambridge biotech, in April but landed a higher-paying, six-figure administrative job at a Boston drug maker within days.

The biotech index fund XBI has climbed nearly 9% so far in 2023 and is up 11.74% over the last six months, trading at $88.80 per share. At its peak on Feb. 5, 2022, the XBI was trading at $166.78.

Brian Buntz, the pharma and biotech editor at Drug Discovery & Development, says companies across the industry have contributed to biotech layoffs in early 2024, driven by factors ranging from ...

After some years of a thriving life sciences job market, the Maryland biotech industry has had more than 1,200 layoffs in the last year, according to the State of Maryland’s Work Adjustment and ...

Layoffs in the biotech industry for 2023 have matched the total number of companies that cut staff in all of 2022, with 119 biopharmas reporting workforce reductions so far this year, according to ...

While the first quarter of 2024 gave hope that the pace of biotech layoffs were slowing down, the last three months changed that narrative. Massachusetts companies disclosed plans to cut more than ...

Layoffs have been a fixture of the biotech industry this year, a symptom of ongoing economic troubles. The fourth quarter was no exception.

In January, tech and biotech companies orchestrated the layoffs of 5,384 employees in Bay Area cities. In March, the projected layoff numbers currently total about 5,248.

Biotech industry leaders share cautious optimism for 2023 amid downturn and layoffs by Charlotte Schubert on December 27, 2022 at 7:53 am Share 8 ...

Layoffs and Shutdowns Hit Biotech Industry in U-Turn After years of easy money and heady growth, funding is slim and stocks are down By Joseph Walker Feb. 10, 2023 5:30 am ET ...